CA2257362C - Process for the selective alkylation of epoxy-alcohols - Google Patents
Process for the selective alkylation of epoxy-alcohols Download PDFInfo
- Publication number
- CA2257362C CA2257362C CA002257362A CA2257362A CA2257362C CA 2257362 C CA2257362 C CA 2257362C CA 002257362 A CA002257362 A CA 002257362A CA 2257362 A CA2257362 A CA 2257362A CA 2257362 C CA2257362 C CA 2257362C
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- halo
- alkyls
- group
- phenoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
Abstract
The hydroxy group of an epoxy-alcohol is selectively alkylated, without affecting the epoxy group, by reaction with an alkylating agent in the presence of a solvent and a strong base. As an example, Betaxolol (4) can be prepared according to scheme (1).
Description
1 . f=ield of the Inyention The present invention relates to a novel process for the preparation of 1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-isopropylamino-propane-2-of hydrochloride by selective afkylation of an intermediate alkoxide with an alkylating agent and a base.
2. Backq_rround of the Invention 1 o The processes typically employed in producing 1-{4-[2-(Cyclopropylmethoxy)ethyl]phenoxy}-3-isopropylamino-propane-2-of (Betaxolol) involved protecting the phenol functional group so that the alcohol could be alkylated. This involves extra protection and subsequent deprotection steps which make the reaction cotsiplicated as well as gives low yields which may further require chromatography to purify product.
US 4,252,984 to Manoury et al., describes benzylation of the phenolic alcohol of 4-hydroxyphenethanoic acid. The ethanoic acid group is then reduced to an alcohol and subsequently alkylated with (bromomethyl)cyclopropane. Reduction with H2 in the presence of a catalyst deprotects the compound back to a phenolic compound. In a final step, 2 o addition of isopropylamine produces the end product, Betaxolol. A silica gel column is used to purify the compound.
US 4,760,182 to Ippolito et al., describes a process for producing Betaxolol by converting 4-hydroxyphenethanol to a phenoxide anion with a base and then reacting.the phenoxide anion with epichlorohydrin to produce 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane. 1-[4-{2-hydroxyethyl)phenoxy]-2,3-epoxypropane is reacted with a primary amine to produce an intermediate of Betaxolol. Protection and deprotection steps are necessary to obtain the final product.
US 5,034,535 to Keding et al., describes reacting 4-[2-methoxyethyl]phenol with (S)-5-hydroxymethyl-3-isopropyloxazolidin-2-one sulfonic acid ester to prepare an intermediate in the preparation of S-metoprolol.
The processes typically employed in producing Betaxolol involve extra protection and deprotection steps which make the reaction complicated. Specifically, the epoxide of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane is not stable toward alkylating reagent since the usual alkylation condition will cause polymerization of the epoxy-alcohol.
This is due to the molecule possessing both a nucleophilic and an electrophilic center. The alkoxide of 1-[4-)2-hydroxyethyl)phenoxy]-2,3-epoxypropane can react with the alkylating reagent as well as the epoxide moiety of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane, leading to the formation of multiple products/polymers.
It is therefore advantageous and preferable to have a process wherein the protection and deprotection steps can be eliminated. In addition, it would be a further advantage to have a process which produces highly pure Betaxolol.
SUMMARY OF THE INVENTION
The present invention relates to a process for the selective alkylation of an alcohol in an epoxy-alcohol compound comprising the steps of reacting the epoxy-alcohol compound in the presence of an alkylating reagent, a solvent and a strong base.
More especially, the invention relates to a process for the selective alkylation of the ethanol hydroxy moiety of 1-[4-(hydroxyethyl)phenoxy]-2,3-epoxypropane comprising the steps of reacting the 1-[4-(hydroxyethyl)phenoxy]-2,3-epoxypropane in the presence of an alkylating reagent, a solvent and a strong base.
The present invention further relates to an improved process for the production of Betaxolol.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a process for producing selective alkylations of alcohol hydroxy groups in compounds which also contain an epoxide functional group. The alcohol hydroxy group of a compound can react with an alkylating reagent in the presence of a strong base without polymerization of the compound due to the reactivity of the epoxide with the alkylating reagent.
The present invention also relates to a novel process for producing intermediates of Betaxolol. The synthetic process for producing intermediates of Betaxolol with the novel alkylation process of the present invention is shown in Scheme 1. The phenolic alcohol of 4-hydroxyphenethanol (1) is usually more readily
US 4,252,984 to Manoury et al., describes benzylation of the phenolic alcohol of 4-hydroxyphenethanoic acid. The ethanoic acid group is then reduced to an alcohol and subsequently alkylated with (bromomethyl)cyclopropane. Reduction with H2 in the presence of a catalyst deprotects the compound back to a phenolic compound. In a final step, 2 o addition of isopropylamine produces the end product, Betaxolol. A silica gel column is used to purify the compound.
US 4,760,182 to Ippolito et al., describes a process for producing Betaxolol by converting 4-hydroxyphenethanol to a phenoxide anion with a base and then reacting.the phenoxide anion with epichlorohydrin to produce 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane. 1-[4-{2-hydroxyethyl)phenoxy]-2,3-epoxypropane is reacted with a primary amine to produce an intermediate of Betaxolol. Protection and deprotection steps are necessary to obtain the final product.
US 5,034,535 to Keding et al., describes reacting 4-[2-methoxyethyl]phenol with (S)-5-hydroxymethyl-3-isopropyloxazolidin-2-one sulfonic acid ester to prepare an intermediate in the preparation of S-metoprolol.
The processes typically employed in producing Betaxolol involve extra protection and deprotection steps which make the reaction complicated. Specifically, the epoxide of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane is not stable toward alkylating reagent since the usual alkylation condition will cause polymerization of the epoxy-alcohol.
This is due to the molecule possessing both a nucleophilic and an electrophilic center. The alkoxide of 1-[4-)2-hydroxyethyl)phenoxy]-2,3-epoxypropane can react with the alkylating reagent as well as the epoxide moiety of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane, leading to the formation of multiple products/polymers.
It is therefore advantageous and preferable to have a process wherein the protection and deprotection steps can be eliminated. In addition, it would be a further advantage to have a process which produces highly pure Betaxolol.
SUMMARY OF THE INVENTION
The present invention relates to a process for the selective alkylation of an alcohol in an epoxy-alcohol compound comprising the steps of reacting the epoxy-alcohol compound in the presence of an alkylating reagent, a solvent and a strong base.
More especially, the invention relates to a process for the selective alkylation of the ethanol hydroxy moiety of 1-[4-(hydroxyethyl)phenoxy]-2,3-epoxypropane comprising the steps of reacting the 1-[4-(hydroxyethyl)phenoxy]-2,3-epoxypropane in the presence of an alkylating reagent, a solvent and a strong base.
The present invention further relates to an improved process for the production of Betaxolol.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a process for producing selective alkylations of alcohol hydroxy groups in compounds which also contain an epoxide functional group. The alcohol hydroxy group of a compound can react with an alkylating reagent in the presence of a strong base without polymerization of the compound due to the reactivity of the epoxide with the alkylating reagent.
The present invention also relates to a novel process for producing intermediates of Betaxolol. The synthetic process for producing intermediates of Betaxolol with the novel alkylation process of the present invention is shown in Scheme 1. The phenolic alcohol of 4-hydroxyphenethanol (1) is usually more readily
-3-alkylated than the alcohol hydroxy moiety in the same compound. Typically, for the alcohol hydroxy moiety to be alkylated, the phenolic alcohol had to be protected, thus adding extra protection and deprotection steps. Such protection and deprotection steps included benzylation of the phenol prior to alkylation of the ethanol moiety and then subsequent hydrogenolysis back to the phenol. After the hydrogenolysis, the epoxide could then be added to the phenol and synthesis of Betaxolol continued.
However, with the process of the present invention, such protection and deprotection steps are eliminated. The process of the present invention thus eliminates extra steps and also results in higher yields of product.
The selective alkylation of the present invention utilizes a reactive alkylating reagent and a strong base. The present invention relates to a process for producing selective alkylations of alcohol hydroxy groups in compounds which also contain an epoxide functional group. As an example, in the production of the Betaxolol, Betaxolol may be produced in three steps with only one isolation necessary. In Scheme l, the competition between the reaction of the ethanol hydroxy moiety of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane (2) with an incoming alkylating reagent and with the epoxide of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane (2) was optimized such that self polymerization with the epoxide was eliminated.
However, with the process of the present invention, such protection and deprotection steps are eliminated. The process of the present invention thus eliminates extra steps and also results in higher yields of product.
The selective alkylation of the present invention utilizes a reactive alkylating reagent and a strong base. The present invention relates to a process for producing selective alkylations of alcohol hydroxy groups in compounds which also contain an epoxide functional group. As an example, in the production of the Betaxolol, Betaxolol may be produced in three steps with only one isolation necessary. In Scheme l, the competition between the reaction of the ethanol hydroxy moiety of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane (2) with an incoming alkylating reagent and with the epoxide of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane (2) was optimized such that self polymerization with the epoxide was eliminated.
-4-Scheme 1.
O
HO ~ \ OH CI -; O~,]~O / \ OH
Bra / \
q.~'~o o '''~
Base, solvent I. Isopropyl;~minc;
2. HCl ~ off 0 / \ O' t 5 ~ HCl Suitable alkylating agents used in the selective alkylation of the present invention 20 include subsiiiuted haloalkyls, halo-substituted cycloaikyls, halo-substituted cycloalkylalkyls, halo-substituted arylalkyls, halo-substituted aryl, halo-substituted alkoxies, halo-substituted arylalkoxies, halo-substituted cycloalkoxies, halo-substituted cycloalkylalkoxies, halo-substituted heterocyclics or halo-substituted (heterocyclic)alkyls.
In addition, sulfonated substituted alkylating agents may be used instead of halo-substituted 2 5 alkylating agents. Alkyl groups include straight or branched chain alkyl radicals containing from 1 to 6 carbon atoms including, but not limited to, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, t-butyl, n-pentyl, 1-methylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 2,2-dimethylpropyl, n-hexyl and the like.
Suitable strong bases used in the selective alkylation of the present invention include, 30 but are not intended to be limited to, potassium tert-butoxide, 1,8-Diazabicyclo [5.4.0]
undec-ene (DBU), alkyllithiums including, but not limited to butyllithium (BuLi), and
O
HO ~ \ OH CI -; O~,]~O / \ OH
Bra / \
q.~'~o o '''~
Base, solvent I. Isopropyl;~minc;
2. HCl ~ off 0 / \ O' t 5 ~ HCl Suitable alkylating agents used in the selective alkylation of the present invention 20 include subsiiiuted haloalkyls, halo-substituted cycloaikyls, halo-substituted cycloalkylalkyls, halo-substituted arylalkyls, halo-substituted aryl, halo-substituted alkoxies, halo-substituted arylalkoxies, halo-substituted cycloalkoxies, halo-substituted cycloalkylalkoxies, halo-substituted heterocyclics or halo-substituted (heterocyclic)alkyls.
In addition, sulfonated substituted alkylating agents may be used instead of halo-substituted 2 5 alkylating agents. Alkyl groups include straight or branched chain alkyl radicals containing from 1 to 6 carbon atoms including, but not limited to, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, t-butyl, n-pentyl, 1-methylbutyl, 2,2-dimethylbutyl, 2-methylpentyl, 2,2-dimethylpropyl, n-hexyl and the like.
Suitable strong bases used in the selective alkylation of the present invention include, 30 but are not intended to be limited to, potassium tert-butoxide, 1,8-Diazabicyclo [5.4.0]
undec-ene (DBU), alkyllithiums including, but not limited to butyllithium (BuLi), and
-5-lithium diisopropytamide (LDA), and phenyllithium. The most preferred base is potassium tart-butoxide.
Solvents which may be used with the present invention include, but are not intended to be limited to, Dimethyl Sulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-Dimethylacetamide (DMA), acetonitrile, dichloromethane, ethyl acetate, and tetrahydrofuran (THF).
The temperature of the reaction is typically run at from about -10°C to about 25°C.
A more preferred temperature range is from about -10°C to about 10°C. A most preferred temperature range is from about -5°C to about 5°C.
t o In accordance with the teaching of the present invention, the selective alkylation of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane (2) in the presence of a strong base produces intermediate, 1-(4-j2-(Cyclopropylmethoxy)ethyl]phenoxy}-2,3-epoxypropane (3). 1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-2,3-epoxypropane may then be reacted with isopropylamine followed by an acid including, but not intended to be limited to.
hydrochloric acid to yield Betaxolol (4).
The following example is merely an example of the process of the present invention utilizing the selective alkylation procedure in the presence of a base.
Example 1 A reaction flask was charged with 1-[4-(2-Hydroxyethyl)phenoxy]-2,3-epoxypropane (140 grams, 0.72 moles), bromomethylcyclopropane (90 milliliters (mL), 125 grams, 0.92 miilimoles) and N,N'-dimethylacetamide (700 mL). The mixture was blanketed with nitogen and stirred at room temperature for 70 minutes and then cooled to 0°
C. Potassium tert-butoxide (120 grams, 1.1 moles) was slowly added. After the addition was completed, the reaction mixture was maintained at 0° C far 3 hours.
The reaction mixture was diluted with aqueous hydrochloric acid (7 Normal, 500 mL). The aqueous mixture was extracted three times with 500 mL portions of heptane. The combined organic extracts were washed twice with 500 mL portions of water and 3o concentrated to an oil by vacuum distallation to give 179 grams (i00%
yield) of 1-(4-[2-(Cyclopropylmethoxy)-ethyl]-phenoxy}-2,3-epoxypropane which was used for the preparation of Betaxolol without additional purification.
Example 2 The oil obtained in Example 1 (179 grams) was dissolved in 400 mL of isopropyiamine. After the reaction solution was refluxed for 2 days, the isopropylamine was distilled off and the residue was dissolved in 200 mL of toluene. The toluene was removed by
Solvents which may be used with the present invention include, but are not intended to be limited to, Dimethyl Sulfoxide (DMSO), N,N-dimethylformamide (DMF), N,N-Dimethylacetamide (DMA), acetonitrile, dichloromethane, ethyl acetate, and tetrahydrofuran (THF).
The temperature of the reaction is typically run at from about -10°C to about 25°C.
A more preferred temperature range is from about -10°C to about 10°C. A most preferred temperature range is from about -5°C to about 5°C.
t o In accordance with the teaching of the present invention, the selective alkylation of 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane (2) in the presence of a strong base produces intermediate, 1-(4-j2-(Cyclopropylmethoxy)ethyl]phenoxy}-2,3-epoxypropane (3). 1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-2,3-epoxypropane may then be reacted with isopropylamine followed by an acid including, but not intended to be limited to.
hydrochloric acid to yield Betaxolol (4).
The following example is merely an example of the process of the present invention utilizing the selective alkylation procedure in the presence of a base.
Example 1 A reaction flask was charged with 1-[4-(2-Hydroxyethyl)phenoxy]-2,3-epoxypropane (140 grams, 0.72 moles), bromomethylcyclopropane (90 milliliters (mL), 125 grams, 0.92 miilimoles) and N,N'-dimethylacetamide (700 mL). The mixture was blanketed with nitogen and stirred at room temperature for 70 minutes and then cooled to 0°
C. Potassium tert-butoxide (120 grams, 1.1 moles) was slowly added. After the addition was completed, the reaction mixture was maintained at 0° C far 3 hours.
The reaction mixture was diluted with aqueous hydrochloric acid (7 Normal, 500 mL). The aqueous mixture was extracted three times with 500 mL portions of heptane. The combined organic extracts were washed twice with 500 mL portions of water and 3o concentrated to an oil by vacuum distallation to give 179 grams (i00%
yield) of 1-(4-[2-(Cyclopropylmethoxy)-ethyl]-phenoxy}-2,3-epoxypropane which was used for the preparation of Betaxolol without additional purification.
Example 2 The oil obtained in Example 1 (179 grams) was dissolved in 400 mL of isopropyiamine. After the reaction solution was refluxed for 2 days, the isopropylamine was distilled off and the residue was dissolved in 200 mL of toluene. The toluene was removed by
-6-vacuum distillation to give 222 grams of 1-(4-[2-(Cyclopropylmethoxy)ethyl]phenoxy)-3-isopropylamino-propane-2-of (Betaxolol free base) which was used for the preparation of the hydrochloride salt without additional purification. The Betaxoiol free base was dissolved in 300 mL of toluene containg 20 mL of isopropanol. A stream of hydrogen chloride gas was passed through the above solution at 0° C until the reaction mixture pH was less than 3Ø The solvent was removed by vacuum distillation, and the residue was crystallized from 400 mL of acetone to give 102 grams (99% pure) of Betaxolol hydrochloride.
Claims (18)
1. A process for the selective alkylation of the ethanol hydroxy moiety of 1-[4-(hydroxyethyl)phenoxy]-2,3-epoxypropane comprising the steps of reacting the 1-[4-(hydroxyethyl)phenoxy]-2,3-epoxypropane in the presence of an alkylating reagent, a solvent and a strong base.
2. A process of claim 1 wherein said alkylating agent is selected from the group consisting of: haloalkyls, halo-substituted cycloalkyls, halo-substituted cycloalkylalkyls, halo-substituted arylalkyls, halo-substituted aryl, halo-substituted alkoxies, halo-substituted arylalkoxies, halo-substituted cycloalkoxies, halo-substituted cycloalkylalkoxies, halo-substituted heterocyclics, and halo-substituted (heterocyclic)alkyls
3. A process of claim 1 wherein said alkylating agent is selected from the group consisting of: sulfonate substituted alkyls, cycloalkyls, cycloalkylalkyls, aryl alkyls, aryl, alkoxies, arylalkoxies, cycloalkoxies, cycloalkylalkoxies, heterocyclics, and halo-substituted (heterocyclic)alkyls.
4. A process of claim 1, 2 or 3, wherein the reaction is carried out at a temperature from below -10°C to about 25°C.
5. A process of claim 1, 2 or 3, wherein the reaction is carried out at a temperature from about -10°C to about 10°C.
6. A process of claim 1, 2 or 3, wherein the reaction is carried out at a temperature from about -5°C to about 5°C.
7. A process of any one of claims 1 to 6, wherein said strong base is selected from the group consisting of: potassium tert-butoxide, 1,8-diazabicyclo [5.4.0]
undecene, alkyllithium, lithium diisopropylamide, and phenyllithium.
undecene, alkyllithium, lithium diisopropylamide, and phenyllithium.
8. A process of any one of claims 1 to 6, wherein said strong base is potassium tert-butoxide.
9. A process of any one of claims 1 to 8, wherein said solvent is selected from the group consisting of: dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, tetrahydrofuran, 1-methyl-2-piperidone, and 1-methyl-2-pyrrolidone.
10. A process for the production of Betaxolol comprising the steps of a) reacting 1-[4-(2-hydroxyethyl)phenoxy]-2,3-epoxypropane with an alkylating reagent in the presence of a solvent and strong base to produce 1-(4-[2-(cyclopropylmethoxy)ethyl]phenoxy)-2,3-epoxypropane; and b) reacting 1-(4-(2-(cyclopropylmethoxy)ethyl]phenoxy)-2,3-epoxypropane with isopropylamine to produce Betaxolol.
11. A process of 10, wherein the reaction in a) is carried out at a temperature from below -10°C to about 25°C.
12. A process of claim 10, wherein the reaction in a) is carried out at a temperature from about -10°C to about 10°C.
13. A process of claim 10, wherein the reaction in a) is carried out at a temperature from about -5°C to about 5°C.
14. A process of claim 10, 11, 12 or 13, wherein said alkylating agent is selected from the group consisting of haloalkyls, halo-substituted cycloalkyls, halo-substituted cycloalkylalkyls, halo-substituted arylalkyls, halo-substituted aryl, halo-substituted alkoxies, halo-substituted arylalkoxies, halo-substituted cycloalkoxies, halo-substituted cycloalkylalkoxies, halo-substituted heterocyclics, and halo-substituted (heterocyclic)alkyls.
15. A process of claim 10, 11, 12 or 13, wherein said alkylating agent is selected from the group consisting of: sulfonate substituted alkyls, cycloalkyls, cycloalkylalkyls, aryl alkyls, aryl, alkoxies, arylalkoxies, cycloalkoxies, cycloalkylalkoxies, heterocyclics, and halo-substituted (heterocyclic)alkyls.
16. A process of any one of claims 10 to 15, wherein said strong base is selected from the group consisting of: potassium tert-butoxide, 1,8-diazabicyclo [5.4.0]
undecene, alkyllithium, lithium diisopropylamide, and phenyllithium.
undecene, alkyllithium, lithium diisopropylamide, and phenyllithium.
17. A process of any one of claims 10 to 16, wherein said strong base is potassium tert-butoxide.
18. A process of any one of claims 10 to 17, wherein said solvent is selected from the group consisting of: dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, tetrahydrofuran, 1-methyl-2-piperidone, and 1-methyl-2-pyrrolidone.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/667,038 US5942633A (en) | 1996-06-19 | 1996-06-19 | Process for the selective alkylation of betaxolol intermediates |
| US08/667,038 | 1996-06-19 | ||
| PCT/US1997/010337 WO1997048690A1 (en) | 1996-06-19 | 1997-06-18 | Process for the selective alkylation of epoxy-alcohols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2257362A1 CA2257362A1 (en) | 1997-12-24 |
| CA2257362C true CA2257362C (en) | 2007-01-23 |
Family
ID=37684481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002257362A Expired - Fee Related CA2257362C (en) | 1996-06-19 | 1997-06-18 | Process for the selective alkylation of epoxy-alcohols |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2257362C (en) |
-
1997
- 1997-06-18 CA CA002257362A patent/CA2257362C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2257362A1 (en) | 1997-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2466779C (en) | Methods for preparing o-desmethylvenlafaxine | |
| CA2856609C (en) | Process for the preparation of sterol derivatives | |
| CA2969920A1 (en) | Processes for the preparation of tasimelteon and intermediates thereof | |
| US20240092743A1 (en) | Methods of making delmopinol and salts thereof | |
| CA2257362C (en) | Process for the selective alkylation of epoxy-alcohols | |
| EP0931055B1 (en) | Selective alkylation of an alcohol substituted phenol compound | |
| US5942633A (en) | Process for the selective alkylation of betaxolol intermediates | |
| IL147668A (en) | Process for the preparation of venlafaxin | |
| MXPA98010590A (en) | Procedure for the selective allocation of epoxy alcohols | |
| CN110734364B (en) | Synthesis method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone | |
| CA1037047A (en) | 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-t-butylaminoethyl)pyridine preparation and intermediate compounds | |
| CN112939849A (en) | (S, S) -2, 8-diazabicyclo [4.3.0] nonane intermediate and preparation method and application thereof | |
| CN115215803B (en) | Preparation method of 4-halogenated-1- (difluoromethyl) -1H-imidazole | |
| MXPA99002754A (en) | Selective alkylation of an alcohol substituted phenol compound | |
| CN115260103B (en) | Preparation method of 4,5-dihalogen-1- (difluoromethyl) -1H-imidazole | |
| EP4144717B1 (en) | Method for purification of terpenoid amino alcohol derivatives | |
| US6562953B2 (en) | Process which is useful for converting the carbonyl function in position 4″ of the cladinose unit of an aza-macrolide into an amine derivative | |
| EP2121574A1 (en) | Improved process for the preparation of phenethylamine derivatives | |
| GB1568976A (en) | Cis-4-phenyl-isoquinolines | |
| WO2007049302A2 (en) | An improved process for the preparation of pure venlafaxine | |
| JP2640688B2 (en) | Carbamate derivatives and methods for their production | |
| JPS58148834A (en) | Manufacture of 5-substituted 1-chloro-3,3- dimethylpentan-2-one | |
| CN115772121A (en) | Preparation method of 2-methylamino-3-hydroxymethylpyridine | |
| WO2001092251A2 (en) | Aryloxy ester and acid compounds | |
| CN110511170A (en) | A kind of synthetic method of chirality nafoxidine -3- carboxylic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20160620 |